Senores Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: SENORES Small Cap ISIN: INE0RB801010

As on 18 November 2025 at 23:55 IST

₹792.75

+ 4.60

(0.58%)

Sell Buy

Over 1 Month

10.25%

Over 6 Months

53.56%

Over 1 Year

41.49%

Over 3 Years

None%

Senores Pharmaceuticals Ltd Summary

Close ₹788.15

Open ₹783

High ₹799.95

Low ₹779

Volume 1,73,891

Net Turnover (in Cr) ₹13.73

52Wk High ₹832

52Wk Low ₹435.25

52Wk High / Low

435.25

832

Senores Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,629.71

EPS (TTM) 2.65

Book Value (BV) 155.06

Div. Yield -

P/E (TTM) 298.02

Price/Book Value 5.09

Delivery % 43.10 %

Face Value 10

Key Ratios

PE Ratio 715.94

PB Ratio 3.73

EV to Sales 61.77

PEG Ratio 3.65

ROA 0.45

ROE 0.84

Debt-Equity 0.23

Net Profit Margin 9.57

Operating Profit Margin 38.17

Senores Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	417.51	217.34	39.02	14.63
Total Expenses	346.94	192.40	26.58	13.49
Profit Before Tax	70.57	24.94	12.44	1.14
Profit After Tax	58.34	32.71	8.43	0.99
Operating Profit After Depreciation	92.12	34.39	14.57	1.71

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Fixed Assets	429.02	314.75	53.65	14.61
Total Non Current Assets	504.43	370.97	79.72	32.10
Total Current Assets	722.43	250.91	51.34	27.05
Total Assets	1,226.86	621.88	131.05	59.15
Total Shareholder's Fund	786.18	204.27	45.50	36.59

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	-45.92	-25.70	-1.08	-10.45
Net Cash Used In Investing Activities	-429.48	-53.73	-48.29	-24.44
Net Cash Used In Financing Activities	573.13	86.98	46.25	36.46

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	60.53	40.85	19.17	14.48	8.06
Total Expenses	55.42	38.82	17.23	13.65	7.66
Profit Before Tax	5.11	2.03	1.94	0.83	0.40
Profit After Tax	3.69	0.81	1.20	0.68	0.84
Operating Profit After Depreciation	11.63	4.74	4.08	1.39	0.60

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	54.59	27.68	11.05	4.76	4.41
Total Non Current Assets	422.02	245.90	84.04	41.19	6.76
Total Current Assets	412.07	39.96	27.68	13.98	8.20
Total Assets	834.09	285.86	111.72	55.17	14.96
Total Shareholder's Fund	707.97	168.12	38.92	33.69	9.47

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-20.40	-19.26	-43.41	-24.06	-2.87
Net Cash Used In Investing Activities	-162.94	-57.07	-5.23	-10.05	-4.37
Net Cash Used In Financing Activities	532.62	86.68	47.08	33.88	8.50

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	161.76	137.99	114.21	103.02	100.63
Total Expenses	112.25	103.83	94.77	77.33	77.36
Profit Before Tax	40.64	26.49	20.68	20.49	15.97
Profit After Tax	30.12	21.18	17.97	16.43	13.07
Operating Profit after Depreciation	54.92	37.52	31.21	30.85	25.13

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	35.33	19.82	11.86	9.59	9.63
Total Expenses	33.81	20.98	14.60	12.01	10.97
Profit Before Tax	7.65	3.59	2.89	1.32	0.54
Profit After Tax	6.43	2.70	2.01	1.07	0.30
Operating Profit after Depreciation	12.88	7.23	6.51	4.77	1.75

Senores Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 778.12

S2 768.08

S3 757.17

Pivot 789.03

R1 799.07

R2 809.98

R3 820.02

Moving Average

20 SMA 772.26

50 SMA 735.30

100 SMA 690.17

200 SMA 615.03

Senores Pharmaceuticals Ltd Corporate Actions

No available data

Senores Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Senores Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Mahindra Manulife Large & Mid Cap Fund	1.84%
Mahindra Manulife Balanced Advantage Fund	0.88%
ICICI Pru P.H.D Fund	0.77%
Bank of India Multi Cap Fund	0.60%
Bank of India Mid & Small Cap Equity & Debt Fund	0.53%

Senores Pharmaceuticals Ltd News

Senores Pharmaceuticals to convene board meeting

On 6 November 2025

30 Oct 2025, 11:09 am

Stock Alert: Senores Pharma, Ramky Infra, Thomas Cook, Sai Life Sciences

19 Sep 2025, 08:17 am

Senores Pharmaceuticals to conduct AGM

On 18 September 2025

28 Aug 2025, 01:40 pm

Senores Pharma gains on US ANDA acquisition from Teva

Senores Pharmaceuticals rose 2.16% to Rs 687.75 after its US arm signed a deal to acquire two USFDA-approved ANDAs from Teva Pharmaceuticals USA, targeting a market size of up to $120 million.

13 Aug 2025, 09:29 am

Senores Pharmaceuticals Ltd leads gainers in 'B' group

Pondy Oxides & Chemicals Ltd, Mukand Ltd, Thyrocare Technologies Ltd and Southern Petrochemicals Industries Corporation Ltd are among the other gainers in the BSE's 'B' group today, 24 July 2025.

24 Jul 2025, 12:15 pm

Senores Pharmaceuticals Ltd Stock Analysis

Annual revenue for Senores Pharmaceuticals Ltd increased by 48.18% to ₹60.53 crore in FY 2025 from ₹40.85 crore in FY 2024.
Annual Net Profit for Senores Pharmaceuticals Ltd increased by 355.56% to ₹3.69 crore in FY 2025 from ₹0.81 crore in FY 2024.
Promoter Shareholding in Senores Pharmaceuticals Ltd increased by 0.03% in the most recent quarter, from 45.78% in June 2025 to 45.80% in September 2025.
Senores Pharmaceuticals Ltd delivered a 1-year return of 41.49% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Senores Pharmaceuticals Ltd share price moved up by 0.58% from its previous close of INR ₹788.15. The latest Senores Pharmaceuticals Ltd share price is INR ₹792.75.
Senores Pharmaceuticals Ltd share price today has been at a low of 781.60 and a high of 803.30. Over the past 52 weeks, the Senores Pharmaceuticals Ltd share price has seen a low of 435.25 and a high of 832.